Pharmaceutical Business Review
Anonymous User | Login

Diamyd Medical wins Swedish approval for diabetes vaccine study

Published: 10-Mar-2009

Study comprises of 50 children from four years of age

Diamyd Medical, a biopharmaceutical company, has announced that the Swedish Medical Products Agency has approved a study with the Diamyd diabetes vaccine in children with high risk to develop type 1 diabetes.

The approved study comprises, under the present approval, up to 50 children from four years of age who are known to have a high risk of developing type 1 diabetes. The study will be randomized and placebo controlled.

If vaccination with Diamyd succeeds to intervene in the disease process before too many of the insulin cells are destroyed, the disease will be prevented. The child would then escape diabetes symptoms and would not become dependent on insulin injections for survival, which otherwise is unavoidable, the company said.

Elisabeth Lindner, president and CEO of Diamyd, said: To vaccinate children against diabetes has from the outset been one of Diamyd Medical's long term goals. Type 1 diabetes is a life-long and very serious disease and it is good if we now can prevent it. It would avoid a lot of anxiety, suffering and costs for the children and their families as well as the rest of society.

Diamyd Medical is a Swedish biopharmaceutical company focusing on development of pharmaceuticals for treatment of autoimmune diabetes and its complications. The company has also started clinical studies on chronic pain. The company also has out-licensed the use of GAD for the treatment of Parkinson's disease.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BaseCon

IT Pharma Solutions ...

ETS Nederland BV

(Experimental Toxicology Services) ...

TNO

Pharma Services: From Discovery to the Clinic ...

Fraunhofer ITEM

Human Health Research ...

Anoto

Providing Unique Technology for Digital Pen and Paper ...

ProtNeteomix

Developing Applications for Drug Discovery & Development and Diagnostics ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

No items to display

Suppliers Product News

Amarna Therapeutics B.V. and TNO Announce SVac Research and Development Partnership

Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.

Organisations Throwing Mobile Technology at Problems With Little Consideration of Actual User and Business Needs, Quocirca

Survey reveals detrimental impact on organisational effectiveness and IT expenditure in healthcare and finance across the UK, France, Germany and the US.

Digital Pen and Paper Technology Helps Accelerate Clinical Trials

Digital pen and paper technology captures handwritten clinical data electronically, quickly and securely to save time and cost in drug discovery process.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address